AMENDMENT NO. 3 TO PURCHASE AGREEMENT SERVICES PHASE 3 # CW1882970 BETWEEN INTELCORPORATION AND IMPINJ, INC.

EX-10.28 32 d94993dex1028.htm AMENDMENT NO. 3 TO PURCHASE AGREEMENT - SERVICES PHASE 2 Amendment No. 3 to Purchase Agreement - Services Phase 2

Exhibit 10.28

AMENDMENT NO. 3 TO

PURCHASE AGREEMENT — SERVICES PHASE 3 # CW1882970

BETWEEN

INTEL CORPORATION AND IMPINJ, INC.

For valuable consideration, the receipt and sufficiency of which the parties hereby acknowledge Intel Corporation (“Intel”) and Impinj, Inc. (“Impinj”) hereby amend the above referenced Purchase Agreement — Services Phase 2 dated on or about December 23, 2009 # CW1882970 (the “Agreement”) as set forth hereafter.

 

1. EFFECTIVE/EXPIRATION DATE

The Effective Date of this amendment (“Amendment”) shall be Nov 15th, 2011.

The new Expiration Date of the Agreement shall be December 31, 2012.

 

2. DEFINITIONS

Unless provided otherwise in this Amendment, each term appearing in this Amendment shall have the same meaning as given in the Agreement.

The term “Service(s)” shall be expanded to include the work to be performed as set forth in Addendum “D”, including any deliverables set forth in Addendum D resulting from such Services.

 

3. AMENDMENTS

By executing this Amendment, Intel and Impinj are amending the Agreement to:

Include Addendum D (Hannegan1 ***) of the Agreement which is attached hereto and incorporated herein by this reference.

 

4. LEGAL EFFECT ON AGREEMENT

As amended by this Amendment, all provisions of the Agreement shall remain in full force and effect. In the event of a conflict between this Amendment and the Agreement, this Amendment shall take precedence.

 

INTEL CORPORATION     IMPINJ, INC.
BY:   /s/ Shahrokh Shahidzadeh     BY:   /s/ Kerry Krause
NAME:   Shahrokh Shahidzadeh     NAME:   Kerry Krause
TITLE:   Sr Principal Technologist     TITLE:   VP Marketing
DATE:   11/15/11     DATE:   11/15/11

 

 

*** Indicates text has been omitted from this Exhibit pursuant to a confidential treatment request and has been filed separately with the Securities and Exchange Commission.


ADDENDUM D

Hannegan1 ***

Statement of Work for Purchase Agreement — Services:

 

  1. Overview

This SoW describes work that Impinj will perform *** Hannegan 1. This SoW:

 

    States the project goal

 

    Defines the roles and responsibilities for the project team members

 

    Lists the deliverables and associated fees

 

  2. Project Goal

This project has one goal:

1. Provide *** Hannegan 1 ***.

 

  3. Roles and Responsibilities

The project team shall comprise personnel from Intel and Impinj.

Intel shall:

 

    Assign a project lead to provide project guidance and responses to Impinj’s questions and who has the authority to accept Impinj deliverables

 

    To the extent Intel deems necessary or desirable, assign engineering resources on a full or part-time basis and provide the name of Intel’s engineering lead at SOW signing

 

    Travel to Impinj facilities as necessary or desirable for engineering meetings and reviewing contract deliverables

 

    Be responsible for *** including but not limited to the *** into Intel’s products

Impinj shall:

 

    Assign a project lead acceptable to Intel who shall have the authority to execute all deliverable commitments

 

    Assign engineering resources on a full or part-time basis and provide the name of Impinj’s engineering lead at SoW signing

 

    Travel to Intel facilities as necessary for engineering meetings and review of deliverables

 

    Use commercially reasonable efforts to demonstrate performance of the *** that *** in Appendix C-1 of this Addendum C

 

  4. Definitions:

Acceptance Criteria: Objective acceptance criteria, agreed to in writing by both Intel and Impinj, for deliverables under this SOW.

 

  5. Project Scope, Fees, and Acceptance Criteria

The project scope shall be for Impinj to *** Hannegan 1.

The project fee shall be *** payable as set forth in the Project Milestones and Deliverables table below. Intel will also reimburse Impinj for additional project-related costs actually incurred by Impinj and approved in advance by Intel, such as travel expenses.

The “Acceptance Criteria” for each milestone are defined in the Project Milestones and Deliverables table below. A deliverable will be accepted if it substantially conforms to each of the Acceptance Criteria for that deliverable. Intel will provide notice of acceptance or rejection of each deliverable within 15 days following Intel’s receipt of the deliverable, and if such notice is not provided within 15 days following receipt the deliverable will be deemed accepted.

 

 

*** Indicates text has been omitted from this Exhibit pursuant to a confidential treatment request and has been filed separately with the Securities and Exchange Commission.


Impinj will provide the deliverables under this SoW “as is” and without warranty of any kind, and Impinj disclaims any implied warranties. Each party’s liability under this SoW will be limited to the total amount of fees paid or payable by Intel as set forth above, and neither party will have any liability for incidental or consequential damages under this SoW. Notwithstanding the foregoing, this Section regarding limitation of liability shall not apply to claims or damages arising from death or personal injury or tangible property damage, from any breaches of obligations of confidentiality, or payments to third parties under the indemnity with respect to hazardous materials.

 

  6. Project Management

The project managers are:

 

For Intel:    For Impinj:
Shahrokh Shahidzadeh    Todd Humes
Intel Corporation    Impinj, Inc.
MS JF1-41    701 North 34th Street
2111 NE 25th Avenue    Suite 300
Hillsboro, OR 97124    Seattle, WA 98103


  7. Project Milestones and Deliverables

The project milestones shall be as defined below. Prior to Impinj’s completion of work, Intel shall review and either accept or request reasonable changes to the deliverables. Impinj shall make reasonable efforts to accommodate Intel’s requested changes.

 

     Milestone    Date   

Deliverables

   Acceptance Criteria    Payment
Upon
Milestone
Completion

1

   Contract Signing
and Purchase
Order from Intel
   2011-11-14    Specs, Terms & Conditions       ***

2

   Hannegan 1 ***    ***    ***    Spec Compliance    ***

3

   ***    ***    ***    ***   

4

   ***    ***    ***    *** Review   

5

   ***    ***    ***    System functional test    ***

6

   ***    ***    ***       ***

 

 

*** Indicates text has been omitted from this Exhibit pursuant to a confidential treatment request and has been filed separately with the Securities and Exchange Commission.


Appendix D-1 – Hannegan1 *** Requirements

 

Parameter

  

Description

   Condition    Min    Nom      Max    Units    Comments

RF Functionality

***

   ***    ***                ***

***

   ***    ***         ***             ***

***

   ***    ***                ***

***

   ***    ***                ***

RF Performance

***

   ***    ***         ***          ***    ***

***

   ***    ***         ***          ***   

***

   ***    ***         ***          ***   

***

   ***            ***          ***   
  

***

                 

***

   ***    ***          ***       ***

***

   ***    ***         ***             ***

***

   ***                  

***

   ***    ***         ***          ***    ***

***

   ***    ***         ***          ***    ***

***

   ***    ***         ***             ***

***

   ***       ***       ***    ***    ***

***

   ***    ***          ***    ***    ***

***

   ***    ***    ***          ***    ***

***

   ***    ***          ***    ***   

***

   ***    ***    ***          ***   

***

   ***    ***          ***    ***   

***

   ***    ***          ***    ***   

***

   ***    ***    ***          ***   
      ***    ***          ***   

***

   ***    ***    ***       ***    ***   

***

   ***    ***          ***    ***   

***

   ***             ***    ***    ***

***

   ***    ***          ***    ***    ***

 

 

*** Indicates text has been omitted from this Exhibit pursuant to a confidential treatment request and has been filed separately with the Securities and Exchange Commission.


Parameter

  

Description

   Condition    Min    Nom    Max    Units    Comments

*** to comply with the Intel Specific Field of Use

***

   ***    ***       ***       ***    ***

***

   ***    ***       ***       ***    ***

***

   ***    ***       ***       ***    ***

***

   ***    ***       ***       ***    ***

***

   ***    ***       ***       ***    ***

***

            ***       ***    ***

 

 

*** Indicates text has been omitted from this Exhibit pursuant to a confidential treatment request and has been filed separately with the Securities and Exchange Commission.


Parameter

  

Description

   Condition    Min    Nom    Max    Units    Comments

***

   ***    ***    ***       ***    ***    ***

DCI

***

   ***    ***       ***    ***    ***    ***
   ***    ***          ***    ***    ***

***

   ***       ***       ***    ***    ***

Physical

***

   ***    ***       ***       ***    ***

***

   ***    ***       ***    ***    ***    ***

***

   ***    ***       ***       ***    ***

 

 

*** Indicates text has been omitted from this Exhibit pursuant to a confidential treatment request and has been filed separately with the Securities and Exchange Commission.


Parameter

  

Description

   Condition    Min    Nom    Max    Units    Comments
Environmental

***

   ***    ***    ***       ***    ***    ***

***

   ***    ***    ***          ***    ***

***

   ***       ***       ***    ***   
   ***    ***    ***       ***    ***   

***

   ***       ***       ***    ***   

***

   ***       ***       ***    ***    ***

***

   ***    ***          ***    ***    ***

 

 

*** Indicates text has been omitted from this Exhibit pursuant to a confidential treatment request and has been filed separately with the Securities and Exchange Commission.


Hannegan1 ***

***

 

 

*** Indicates text has been omitted from this Exhibit pursuant to a confidential treatment request and has been filed separately with the Securities and Exchange Commission.


***

   ***    ***    ***

***

   ***    ***    ***

***

   ***    ***    ***

***

   ***    ***    ***

***

   ***    ***    ***

***

   ***    ***    ***

***

   ***    ***    ***

***

   ***    ***    ***

***

   ***    ***    ***

***

   ***    ***    ***

***

   ***    ***    ***

***

   ***    ***    ***

***

   ***    ***    ***

***

   ***    ***    ***

***

   ***    ***    ***

***

   ***    ***    ***

***

   ***    ***    ***

***

   ***    ***    ***

*** showing the *** for ***

 

 

*** Indicates text has been omitted from this Exhibit pursuant to a confidential treatment request and has been filed separately with the Securities and Exchange Commission.